Biotech
ABO-Group pivots to defence and nuclear as construction slows
The Belgian geotechnics firm hit €106.5m revenue in 2025 by trading cyclical construction exposure for defence and nuclear contracts.
The Belgian geotechnics firm hit €106.5m revenue in 2025 by trading cyclical construction exposure for defence and nuclear contracts.